Phorbol Ester Reduces Phosphorylation of Epidermal Growth Factor Receptor in Pancreatic Cancer Cells by Activation of a Tyrosine Phosphatase
- 30 November 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 265 (3) , 728-733
- https://doi.org/10.1006/bbrc.1999.1656
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Systemic treatment with epidermal growth factor in pigs induces ductal proliferations in the pancreas.Gastroenterology, 1997
- Tyrosine Kinase Inhibition: An Approach to Drug DevelopmentScience, 1995
- Inhibition of epidermal growth factor‐dependent protein tyrosine phosphorylation by phorbol myristate acetate is mediated by protein tyrosine phosphatase activityFEBS Letters, 1994
- Localization of immunoreactive epidermal growth factor receptor in neonatal and adult rat hippocampusBrain Research, 1993
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.Journal of Clinical Investigation, 1992
- Characterization of two monoclonal antibodies against the COOH-terminal part of the human epidermal growth factor receptor and potential clinical useJournal of Immunological Methods, 1991
- Epidermal growth factor regulates the expression of its own receptor.Proceedings of the National Academy of Sciences, 1985
- Phorbol esters induce transient internalization without degradation of unoccupied epidermal growth factor receptors.Proceedings of the National Academy of Sciences, 1985
- Different responses to EGF in two human carcinoma cell lines, A431 and UCVA-1, possessing high numbers of EGF receptorsMolecular and Cellular Endocrinology, 1984
- A monoclonal antibody to the human epidermal growth factor receptorJournal of Cellular Biochemistry, 1982